• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Present and Future Dyslipidemia Therapies for Reducing Cardiovascular Risk and Cardiovascular Disease Incidence

Present and Future Dyslipidemia Therapies for Reducing Cardiovascular Risk and Cardiovascular Disease Incidence

Paperback

Medical ReferenceBiology

PREORDER - Expected ship date June 1, 2029

ISBN10: 0323900569
ISBN13: 9780323900560
Publisher: Academic Press
Published: Jun 1 2029
Pages: 160
Language: English

In the last few decades, statins had been widely used to successfully lower ASCVD risk. Despite the efficacy of statins in reducing CVD events in primary and secondary prevention patients, there is still substantial residual risk and initial and recurring CVD events remaining in these patient groups.

Also in

Medical Reference